Breathing Machines Market Size, Share, Growth, and Industry Analysis, By Type (Asthma Nebulizers, PAP Machines, Oxygen Concentrator, and Ventilators), By Application (Hospitals & Clinics, Home Healthcare), Regional Forecast To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
-
Request a Free sample to learn more about this report
BREATHING MACHINES MARKET OVERVIEW
The global breathing machines market was valued at USD 8.46 billion in 2024 and is expected to rise to USD 8.86 billion in 2025, eventually reaching USD 13.41 billion by 2033, expanding at a CAGR of 4.76% from 2025 to 2033.
Breathing machines are equipment that are used as an artificial substitution for autonomous ventilation. Its primary application to support respiration when the respiratory system fails due to certain causes like anaesthesia and respiratory management during major surgery, respiratory support therapy and first aid resuscitation.
Basing on the end user, hospitals are the primary consumer base of these products. Almost all patient whenever they undergo any medical procedure irrespective of the fact whether they have any existing breathing conditions or not, there is a requirement for some respiratory support. Thus, breathing machines are an indispensable instrument in any medical facility.
BREATHING MACHINES MARKET KEY FINDINGS
- Market Size and Growth: Valued at 8.86 billion in 2024, expected to reach 13.43 billion by 2033, growing at a CAGR 4.76%
- Key Market Driver: Aging population share grew by 87% between 1974 and 2024
- Major Market Restraint: Ventilator production spike of 64.5% in 2020 strained component suppliers
- Emerging Trends: Pediatric-capable ventilators constitute 18.1% of U.S. supply
- Regional Leadership: North America holds 35.7% share of the global ventilator market
- Competitive Landscape: Getinge and Hamilton Medical each command 22% share of ICU ventilators
- Market Segmentation: Non-invasive ventilation modes captured 57.7% share in 2023
- Recent Development: Intensive care ventilators dominated with 65.2% market share in 2023
COVID-19 IMPACT
Pandemic Increased the Market Demand
The COVID-19 outbreak had caused the world to become more aware of the threats possessed by respiratory diseases. While numerous patients around the world were being diagnosed with pneumonia and other such ailments, countries like China, Italy and US among others put in all their efforts to build new hospitals and better healthcare facilities to treat such growing patient population having severe respiratory problems. This increased state of caution as a result of the pandemic has case the healthcare and the non-healthcare sectors form an alliance in order to manufacture more breathing machines and respiratory care devices.
LATEST TRENDS
Rise in innovation by market players has caused a preferential shift towards vibrating mesh nebulizers resulting in an upsurge in the adoption of the system
The major manufacturers are working towards a substantial advancements in the respiratory device in order to dispense medication at a consistent particle size and as a result the experience of administering medication in becoming more comfortable. This has led to the increase in the use of vibrating mesh nebulizers.
These contributions towards making the use of the device more comfortable is expected to upsurge the adoption of these systems. The introduction of such innovations with increased portability has caused the demand for such devices to increase. Furthermore, the rising awareness among the general mass as well as the healthcare specialists about the threats posed by these respiratory ailments has caused them to look for better, more reliable options in the healthcare sector leading to the employment of such cutting edge technology.
- In the U.S., full-featured hospital ventilators account for 38.8% of the total installed base (62 000 of 160 000 units)
- Pediatric-capable ventilators represent 18.1% of the U.S. supply (29 000 of 160 000 units)
BREATHING MACHINES MARKET SEGMENTATION
By Type Analysis
According to type, the market can be segmented into Asthma Nebulizers, PAP Machines, Oxygen Concentrator, and Ventilators
By Application Analysis
Based on application, the market can be divided into Hospitals & Clinics, Home Healthcare, Others.
DRIVING FACTORS
Outbreak of infectious diseases that are attacking the human respiratory system.
The sudden outbreak of COVID-19 which had a severe impact on the respiratory system even after a recovery has caused the people at large to become more cautious. While people couldn’t help but watch how the shortage of oxygen developing into such a global crisis in these wanting times has led them to prepare better for any future threats. This has led to a rise in demand for personal equipment and ventilators among others. The government as well as the industrial sectors have responded to such high demands by manufacturing more units.
Rise in the number of chronic obstructive pulmonary diseases is expected to spur growth in the market
Chronic obstructive pulmonary diseases (COPD) like TB, asthma, and pneumonia is on the rise due to the increased air pollution, degrading air quality and other factors. In U.S. itself millions of people are suffering from breathing problems due to such diseases. While chronic diseases like such are life-threatening, people have found it more cost-effective to rely on home care devices. The tremendous cost of treatment to such ailments in hospitals have caused people to shift their preferences to undergo treatments in home-care settings. This has been driving the demand of home-care breathing machines resulting in the breathing machines market growth.
- Between 1974 and 2024, the share of global population aged 65 and over almost doubled from 5.5% to 10.3%
- By 2030, people aged 60 and over will comprise 16.7% of the world’s population, up from 12.5% in 2020
RESTRAINING FACTORS
Unfavorable chances of being sufficiently reimbursed to hinder market growth
Owing to the in affordability of the surging healthcare expenses by the masses, a large number of people rely on reimbursements to receive treatment. However, this has caused a serious hindrance in the growth of the market since the reimbursement policies adopted by the companies are reluctant to facilitate such diagnoses and treatments. Only a few devices like PAP devices and oral appliances are covered by such insurance. Hence this has rendered a lower breathing machines market due to the fact that the devices that don’t come under the purview of insurance coverage.
- Global ventilator production surged by 64.5% in 2020, leading to supply chain bottlenecks for components
- The U.S. Strategic National Stockpile holds only 12 000–13 000 ventilators, covering under 10% of U.S. hospital needs
-
Request a Free sample to learn more about this report
BREATHING MACHINES MARKET REGIONAL INSIGHTS
Asia-Pacific to experience the highest growth owing to the growing number of respiratory patients
Asia-Pacific region is forecasted to experience the highest growth during the period owing to the growing number of respiratory patients in that region. This has resulted in a significant growth in the healthcare expenditure and development of healthcare infrastructure to support this growth. Other contributing factors are rising per capita income, growing middle-class population and prevalence of tobacco smoking. Furthermore, medical tourism is surging in this region due to the low infrastructure and treatment cost and availability of highly qualified physicians.
KEY INDUSTRY PLAYERS
Applying collaborative efforts through mergers and acquisitions to influence the market
There are several major players that constitute the breathing machines market. The key players are employing several strategies like mergers and acquisitions, accompanied by the technological researches and advancements leading to the launch of new products by major manufacturers. These are helping them to strengthen their market position and increase their market value.
- GE Healthcare: Accounts for 3% of ICU ventilators globally
- Air Liquide: Represents 3% of mobile ventilator market share
List of Top Breathing Machines Companies
- PARI
- Maquet
- Medtronic
- GE Healthcare
- Air Liquide
- Fisher & Paykel
- Mindray
- Resmed
- Invacare
- MEKICS
- Drager Medical
- Yuwell
- Philips Healthcare
- ORMON
- BD
- Weinmann
- Teijin Pharma
REPORT COVERAGE
This report examines an understanding of the breathing machines market’s size, share, and growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.
Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.
Attributes | Details |
---|---|
Market Size Value In |
US$ 8.46 Billion in 2024 |
Market Size Value By |
US$ 13.41 Billion by 2033 |
Growth Rate |
CAGR of 4.76% from 2024 to 2033 |
Forecast Period |
2024-2033 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The breathing machines market is expected to touch USD 13.41 billion by 2033.
The breathing machines market is expected to exhibit a CAGR of 4.76% over forecast period.
Outbreak of infectious diseases attacking the respiratory system and a rise in the number of chronic obstructive pulmonary diseases.
PARI, Maquet, Medtronic, GE Healthcare, Air Liquide, Fisher & Paykel, Mindray, Resmed, Invacare, MEKICS, Drager Medical, Yuwell, Philips Healthcare, ORMON, BD, Weinmann, Teijin Pharma are the top companies operating in the breathing machines market.